Search

everythinglearnresearchcommunity

for

Search:↓

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Testosterone helps human pancreatic cells increase insulin release.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.